Gambogic Acid as a Non-Competitive Inhibitor of ATP-Binding Cassette Transporter B1 Reverses the Multidrug Resistance of Human Epithelial Cancers by Promoting ATP-Binding Cassette Transporter B1 Protein Degradation
Author:
Publisher
Wiley
Subject
Pharmacology,Toxicology,General Medicine
Reference44 articles.
1. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway;Pandey;Blood,2007
2. Chemistry and biology of the caged Garcinia xanthones;Chantarasriwong;Chemistry,2010
3. Gambogic acid inhibits the catalytic activity of human topoisomerase II alpha by binding to its ATPase domain;Qin;Mol Cancer Ther,2007
4. Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins;Zhai;Mol Cancer Ther,2008
5. Mechanisms of gambogic acid-induced apoptosis in non-small cell lung cancer cells in relation to transferrin receptors;Zhu;J Chemother,2009
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The prevention of multi-drug resistance in cancers through the application of nanotechnology-based targeted delivery systems for combination therapies involving traditional Chinese medicine;Pharmacological Research - Modern Chinese Medicine;2024-03
2. Non-Nutritive Sweeteners Acesulfame Potassium and Sucralose Are Competitive Inhibitors of the Human P-glycoprotein/Multidrug Resistance Protein 1 (PGP/MDR1);Nutrients;2023-02-23
3. Synergic effect of anticancer peptide CIGB-552 and Cisplatin in lung cancer models;Molecular Biology Reports;2022-01-30
4. The combination of nanotechnology and traditional Chinese medicine (TCM) inspires the modernization of TCM: review on nanotechnology in TCM-based drug delivery systems;Drug Delivery and Translational Research;2021-07-14
5. Ligand decorated biodegradable nanomedicine in the treatment of cancer;Pharmacological Research;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3